No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic
RV Dave, H Bromley, VP Taxiarchi, E Camacho… - British Journal of …, 2022 - bjgp.org
Background Women with breast pain constitute >20% of breast clinic attendees. Aim To
investigate breast cancer incidence in women presenting with breast pain and establish the …
investigate breast cancer incidence in women presenting with breast pain and establish the …
Valuing the health states associated with breast cancer screening programmes: a systematic review of economic measures
Policy decisions regarding breast cancer screening and treatment programmes may be
misplaced unless the decision process includes the appropriate utilities and disutilities of …
misplaced unless the decision process includes the appropriate utilities and disutilities of …
[HTML][HTML] Valuing preferences for treating screen detected ductal carcinoma in situ
Background Mammographic screening reduces breast cancer mortality but may lead to the
overdiagnosis and overtreatment of low-risk breast cancers. Conservative management may …
overdiagnosis and overtreatment of low-risk breast cancers. Conservative management may …
[HTML][HTML] Results of shared learning of a new magnetic seed localisation device–A UK iBRA-NET breast cancer localisation study
JL Morgan, HL Bromley, RV Dave, Y Masannat… - European Journal of …, 2022 - Elsevier
Introduction Shared learning is imperative in the assessment and safe implementation of
new healthcare interventions. Magnetic seeds (Magseed®) potentially offer logistical benefit …
new healthcare interventions. Magnetic seeds (Magseed®) potentially offer logistical benefit …
A novel mixed-methods platform study protocol for investigating new surgical devices, with embedded shared learning: iBRA-NET breast lesion localisation study
HL Bromley, R Dave, C Holcombe… - … Journal of Surgery …, 2021 - journals.lww.com
Introduction: New medical devices must have adequate research, such that outcomes are
known, enabling patients to be consented with knowledge of the safety and efficacy of the …
known, enabling patients to be consented with knowledge of the safety and efficacy of the …
Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast …
…, C Nickson, GB Mann, A Park, H Bromley… - Expert Review of …, 2021 - Taylor & Francis
Background:Although evaluations of breast cancer screening programs frequently estimate
quality-adjusted life-year (QALY) losses by stage, other breast cancer characteristics …
quality-adjusted life-year (QALY) losses by stage, other breast cancer characteristics …
[HTML][HTML] Gynaecomastia: when and why to refer to specialist care
HL Bromley, R Dave, N Lord, P Wright… - The British Journal of …, 2021 - ncbi.nlm.nih.gov
186 British Journal of General Practice, April 2021 further increase the risk of gynaecomastia.
Rapid breast enlargement should raise concerns about a hormone-secreting tumour. …
Rapid breast enlargement should raise concerns about a hormone-secreting tumour. …
[HTML][HTML] Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review
HL Bromley, M Varughese, DC Gilbert… - BMJ …, 2024 - bmjoncology.bmj.com
Objective To review the efficacy and safety of low-dose versus standard-dose enzalutamide,
apalutamide or darolutamide treatment for metastatic prostate cancer. Methods and …
apalutamide or darolutamide treatment for metastatic prostate cancer. Methods and …
Management of the High-Risk Patient
S Chatterjee, HL Bromley - Breast Diseases, 2023 - taylorfrancis.com
Breast cancer is the most common cancer in women worldwide in both the developed and
less developed world. It is thus common practice for women to disclose a family history of …
less developed world. It is thus common practice for women to disclose a family history of …
The financial impact of a breast cancer detected within and outside of screening: lessons from the Australian Lifepool cohort
…, GB Mann, L Velentzis, HL Bromley… - Australian and New …, 2020 - Wiley Online Library
Objective: To determine the government and out‐of‐pocket community costs (out‐of‐hospital
medical services and prescription medicines) associated with screen‐detected and …
medical services and prescription medicines) associated with screen‐detected and …